Skip to search formSkip to main contentSkip to account menu

SB 275833

Known as: SB-275833, SB275833 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

retapamulin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
An Evaluation of the Sensititre ® Dried Susceptibility Plate compared with CLSI (M7) Reference Broth Microdilution Method with the New Antimicrobial Agent, Retapamulin
Background: Retapamulin (RE, SB-275833), a novel pleuromutilin with a unique mode of action and no target specific cross… 
2005
2005
Quality Control Guidelines for Susceptibility Testing of Retapamulin (SB-275833) by Reference and Standardized Methods
Pleuromutilin was discovered in 1951 from an edible mushroom, Pleurotus mutilus , but it was not until the early 1970s that its… 
2005
2005
In Vitro Activity of Retapamulin (SB-275833), a Novel Topical Antimicrobial, against 3721 Gram-Positive Isolates Associated with Skin and Skin Structure Infections (SSSIs) From 17 Sites in North…
®, Cleveland, OH, USA) was used for all Staphylococcus species. Fresh lysed horse blood (Hemostat Laboratories, Dixon, CA, USA… 
2005
2005
Retapamulin (SB-275833), a Novel Pleuromutilin - a Multi-center Global Surveillance of Activity Against 3,797 Beta and Alpha Hemolytic Streptococci Isolated from Skin and Skin Structure Infections…
Background: Retapamulin is a novel pleuromutilin currently in development as a topical antimicrobial agent for the treatment of… 
2005
2005
Retapamulin (SB-275833), A Novel Topical Pleuromutilin, Is Active Against Community Associated Methicillin- and Mupirocin-Resistant S. aureus Isolates From Uncomplicated Skin And Skin Structure…
Standards [NCCLS]) guidelines. Results: Methicillin resistance (MRSA) was detected in 649/1975 (32.9%) of S. aureus isolates… 
2005
2005
Gram Positive Isolates Associated with Skin and Skin Structure Infections (SSSIs) and Collected from Sites in the United States are Highly Susceptible to Retapamulin (SB275833), a Novel Topical…
a %Sus %Int %Res Range MIC50 MIC90 Retapamulin NA NA NA 0.008-0.12 0.03 0.06 Amox-Clav b NA NA NA "0.015-0.5 "0.015 0.12… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)